| 12319671 |
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof |
Hua Zhou, John J. Acton, III, Michael J. Ardolino, Yi-Heng Chen, Peter H. Fuller +15 more |
2025-06-03 |
|
| 12030872 |
N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof |
Vladimir Simov, William P. Kaplan, John J. Acton, III, Michael J. Ardolino, Joanna L. Chen +10 more |
2024-07-09 |
$173,599,000 |
| 10975084 |
KDM5 inhibitors |
Umar Faruk Mansoor, Christian Fischer, Phieng Siliphaivanh, Hakan Gunaydin, David L. Sloman |
2021-04-13 |
$189,450,000 |
| 10059705 |
Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors |
Christopher J. Dinsmore, Peter H. Fuller, David Joseph Guerin, Jason Katz, Christopher F. Thompson +9 more |
2018-08-28 |
$100,134,000 |
| 9969749 |
Inhibitors of IRAK4 activity |
Michael D. Altman, Brian M. Andresen, Jason D. Brubaker, Matthew L. Childers, Anthony Donofrio +9 more |
2018-05-15 |
$97,235,000 |
| 9957264 |
Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors |
Matthew L. Childers, Peter H. Fuller, David Joseph Guerin, Jason Katz, Qinglin Pu +11 more |
2018-05-01 |
$129,774,000 |
| 9943516 |
Inhibitors of IRAK4 activity |
Michael D. Altman, Brian M. Andresen, Jason D. Brubaker, Anthony Donofrio, Thierry O. Fischmann +8 more |
2018-04-17 |
$82,364,000 |
| 9725445 |
Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors |
Matthew L. Childers, Christopher J. Dinsmore, Peter H. Fuller, David Joseph Guerin, Jason Katz +14 more |
2017-08-08 |
$65,756,000 |
| 9394282 |
Pyrazole carboxamides as Janus kinase inhibitors |
Jason D. Brubaker, Joshua Close, Tony Siu, Graham F. Smith, Hyun Chong Woo +3 more |
2016-07-19 |
$196,330,000 |
| 9328099 |
Cyanomethylpyrazole carboxamides as janus kinase inhibitors |
Jason D. Brubaker, Matthew L. Childers, Matthew Christopher, Joshua Close, Jason Katz +8 more |
2016-05-03 |
$59,926,000 |
| 8962608 |
Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors |
Jason D. Brubaker, Christopher J. Dinsmore, Dawn Marie Hoffman, Joon Jung, Duan Liu +5 more |
2015-02-24 |
$132,352,000 |
| 8318735 |
2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |
Gerald W. Shipps, Jr., Cliff C. Cheng, Xiaohua Huang, Thierry Olivier Fischmann, Jose S. Duca +12 more |
2012-11-27 |
$59,805,000 |
| 8293747 |
Heterocyclic amide compounds as protein kinase inhibitors |
Panduranga Adulla P. Reddy, Lianyun Zhao, Praveen K. Tadikonda, Tzu-Tshin Wong, Shuyi Tang +3 more |
2012-10-23 |
$53,632,000 |
